Business
BIO-key Shares Expected to Temporarily Move to OTC™ Markets Tomorrow, Wednesday May 13th Following Nasdaq Suspension After Today’s Market Close; BIO-key is Seeking to Restore Nasdaq Listing Expeditiously
HOLMDEL, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced that it has received written notification from The Nasdaq Stock Market LLC that the trading of its common stock will be suspended on Nasdaq effective with markets’ close today, Tuesday, May 12, 2026. BIO-key has received approval from OTC Markets Group for its common stock to be quoted on th
About this update from Bio-key International, Inc.
[{"type":"image","alt":"BIO-key International, Inc.","displaySize":"","headline":null,"caption":"BIO-key International, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":169,"url":"https://media.zenfs.com/en/globenewswire.com/94a8d3cbec770ac8055020cd853d1013"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pDacC.czWUYH8YWAl50fwQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIzNw--/https://media.zenfs.com/en/globenewswire.com/94a8d3cbec770ac8055020cd853d1013","width":300,"height":169},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/pDacC.czWUYH8YWAl50fwQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTIzNw--/https://media.zenfs.com/en/globenewswire.com/94a8d3cbec770ac8055020cd853d1013","width":300,"height":169}},"lazy":false},{"type":"text","content":"HOLMDEL, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, today announced that it has received written notification from The Nasdaq Stock Market LLC that the trading of its common stock will be suspended on Nasdaq effective with markets’ close today, Tuesday, May 12, 2026. BIO-key has received approval from OTC Markets Group for its common stock to be quoted on the OTC Market under the same symbol commencing May 13, 2026. BIO-key’s shares are being suspended because its closing bid price, which has been above $1 the past eight consecutive trading days, did not meet Nasdaq’s extension requirement that its closing bid price be above $1 for a minimum of ten or more consecutive trading days by May 4th and because the Company has not yet to filed its Annual Report on Form 10K for the year ended December 31, 2025.","length":953,"tagName":"p"},{"type":"text","content":"Under Nasdaq rules, BIO-key intends to request a hearing before a Nasdaq Hearings Panel to demonstrate compliance and the resumption of trading on the Nasdaq Capital Market, however there can be no assurance the Hearings Panel will grant relief from Nasdaq suspension.","length":268,"tagName":"p"},{"type":"text","content":"BIO-key Chairman and CEO Michael DePasquale commented, “Through shareholder support and our concerted efforts to regain compliance with Nasdaq’s continued listing standards via a reverse split, we have restored our share price to a level well in excess of Nasdaq’s $1 minimu...